Table 3

Follow-up variables

CharacteristicsControl (n=45)rhTM* (n=47)OR (95% CI)p Value
Sepsis-induced hypotension,† n (%)26 (57.8)17 (36.1)0.42 (0.96 to 6.09)0.059*
Vasopressor, n (%)27 (60.0)16 (34.0)0.35 (0.13 to 0.87)0.021*
Norepinephrine, n (%)23 (51.1)13 (28.9)
Dopamine, n (%)1 (2.2)1 (2.2)
Dobutamine, n (%)1 (2.2)1 (2.2)
Epinephrine, n (%)2 (4.45)1 (2.2)
Bacteraemia (blood culture positive)22 (48.9)29 (61.7)1.67 (0.68 to 4.19)0.294*
Site of infection, n (%)0.795‡
 Lung17 (37.8)19 (40.4)
 Urinary tract/kidney18 (40.0)13 (27.7)
 Gastrointestinal8 (8.8)5 (10.6)
 Skin/soft tissue3 (6.7)4 (8.5)
 Others2 (44.4)3 (6.4)
Responsible organism
 Gram-negative rod27 (60.0)32 (68.0)1.42 (0.56 to 3.66)0.515*
 Gram-positive coccus18 (40.0)15 (31.9)
Antibiotic
 Carbapenem26 (57.8)31 (66.0)0.530‡
 Cephalosporin18 (40.0)14 (29.8)
 Other1 (2.2)2 (4.3)
 Renal replacement therapy, n6 (13.3)5 (10.6)0.78 (0.17 to 3.33)0.756*
 Duration, day9.0 (8.3, 13.5)§3.0 (2.0, 6.0)§NA0.099¶
 Mechanical ventilation, n (%)26 (57.8)21 (44.7)0.59 (0.24 to 1.46)0.220*
  • *Fisher's exact test was performed.

  • †Sepsis-induced hypotension was defined as follows; despite adequate fluid resuscitation, vasopressors required to maintain mean arterial pressure ≥65 mm Hg.

  • ‡χ2 Test was performed.

  • §The data were shown median and 25th and 75th centiles (25, 75 perventile).

  • ¶Mann-Whitney test was performed.

  • NA, none available; rhTM, recombinant human thrombomodulin.